molecular diagnostics

Amid Zand interviews Dr. Patrick Hurban of Expression Analysis, a Quintiles Company on 30 April, 2015.  Dr. Hurban will be speaking at the Knowledge Foundation & Cambridge Healthtech Institute’s Ninth International Sample Prep Technologies, June 25-26, in Bethesda, MD. His talk will examine use of NGS assays to compare results obtained from matched formalin-fixed and frozen tissue specimens.

For more information visit http://www.SamplePrepConference.com/

Sample Prep Technologies 2015 | Sample Preparation and Specimen Quality for NGS assays

Dr. David Barton summarizes the new EU IVD regulations and highlights their key features. He will explain what the ramifications of introducing these new regulations for labs and manufacturers will be and advice for people preparing for the change.

For more information, please visit http://www.MolecularDXEurope.com/mdxe_content.aspx?id=190671

Molecular Diagnostics Europe 2018 | The New EU IVD Regulation – What Will It Mean for Your Lab?

Prof. Joshua Krieger from Harvard Business School shares his perspectives on some of the challenges and opportunities in commercialization of diagnostic tests and gives us a preview of his business case study on Genomic Health.

For more information, please visit https://www.NextGenerationDx.com/Commercialization-Molecular-Diagnostics

Next Generation Dx 2019 | Launch a Paradigm Shift through an Innovative Diagnostic Test

GENcast Interview with Quanterix CEO Kevin Hrusovsky

The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.